Meet the Expert


There are 9 interesting Meet the Expert Sessions sponsored by our industrial partners, who chose the topics and speakers.

Wednesday, 16.11.2022

10:10 - 10:30 a.m.

AstraZeneca AG
Swiss CLL experience with the 2nd generation BTKi Acalabrutinib

3:10 - 3:30 p.m.

Gilead Sciences Switzerland Sàrl
Treatment considerations in advanced and metastatic triple negative breast cancer

 

Thursday, 17.11.2022

10:10 - 10:30 a.m.

Bayer (Schweiz) AG
Early treatment intensification in metastatic hormone-sensitive prostate cancer:
Which patients benefit?

10:10 - 10:30 a.m.

Novartis Pharma Schweiz AG
OS Data: Significance for Clinical Routine and Therapeutic Decision-Making

3:10 - 3:30 p.m.

Astellas Pharma AG
In times of IO and Targeted Therapies - AE management in mUC

3:10 - 3:30 p.m.

Janssen-Cilag AG
Evolving treatment options and practices in EGFR-mutant NSCLC

 

Friday, 18.11.2022

10:10 - 10:30 a.m.

Advanced Accelerator Applications

10:10 - 10:30 a.m.

Blueprint Medicines GmbH
Advanced Systemic Mastocytosis – Recent advances and Swiss experience

3:10 - 3:30 p.m.

BeiGene Switzerland GmbH
Latest developments in WM: meet the expert session

 

Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.